As multiple cytokines share gp130 subunit as the signal transducer, inhibition of JAK/STAT pathway allows simultaneous disruption of multiple cytokines’ signaling (75) and JAK inhibitors thus represent potential therapeutic agents to derail gp130 downstream signaling cascades in SLE. The gene discussed is IL6ST; the disease is systemic lupus erythematosus.